Synthetically Lethal Nanoparticles for Treatment of Endometrial Cancer

Uterine serous carcinoma, one of the most aggressive types of endometrial cancer, is characterized by poor outcomes and mutations in the tumor suppressor p53. Our objective was to engender synthetic lethality to paclitaxel, the frontline treatment for endometrial cancer, in tumors with mutant p53 an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Nanotechnol
Main Authors: Ebeid, Kareem, Meng, Xiangbing, Thiel, Kristina W, Do, Anh-Vu, Geary, Sean M, Morris, Angie S, Pham, Erica L, Wongrakpanich, Amaraporn, Chhonker, Yashpal S, Murry, Daryl J, Leslie, Kimberly K, Salem, Aliasger K
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762267/
https://ncbi.nlm.nih.gov/pubmed/29203914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41565-017-0009-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados